<DOC>
	<DOCNO>NCT01456000</DOCNO>
	<brief_summary>The purpose study demonstrate safety effectiveness CardioFocus Endoscopic Ablation System Adaptive Contact ( HeartLight ) treatment atrial fibrillation create electrical isolation pulmonary vein .</brief_summary>
	<brief_title>HeartLight Ablation Patients With Paroxysmal Atrial Fibrillation ( PAF )</brief_title>
	<detailed_description>A randomize , control trial design demonstrate safety effectiveness experimental device deliver pulmonary vein isolation treatment symptomatic atrial fibrillation .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>18 75 year . paroxysmal atrial fibrillation failure least one AAD others overall good health establish multiple criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>AF</keyword>
	<keyword>PAF</keyword>
	<keyword>PVI</keyword>
	<keyword>ablation</keyword>
	<keyword>paroxysmal atrial fibrillation</keyword>
	<keyword>pulmonary vein isolation</keyword>
</DOC>